Table 2.
Clinical and histological characteristics of patients with glioma
| TCGA (RNA-Seq) | GSE16011 | GSE4412 | GSE4271 | |||||
|---|---|---|---|---|---|---|---|---|
| LGG | GBM | LGG | GBM | LGG | GBM | LGG | GBM | |
| 516 | 154 | 109 | 159 | 26 | 59 | 24 | 76 | |
| Sex | ||||||||
| Male | 285 | 99 | 72 | 108 | 6 | 26 | 16 | 52 |
| Female | 230 | 54 | 37 | 51 | 20 | 33 | 8 | 24 |
| Unknown | 1 | 1 | ||||||
| Age | ||||||||
| Median (LQ-UQ) | 41 (32–53) | 60 (52–70) | 44 (37–55) | 55 (46–64) | 34 (31–41) | 47 (39–61) | 35 (32–43) | 49 (40–55) |
| Histology | ||||||||
| Astro. | 194 (37.6%) | 29 (24.8%) | 8 (30.8%) | |||||
| GBM | 154 (100%) | 159 (100%) | 59 (100%) | |||||
| Oligoastro. | 130 (25.2%) | 28 (23.9%) | 7 (26.9%) | |||||
| Oligodendro. | 191 (37.0%) | 52 (44.4%) | 11 (42.3%) | |||||
| Pilocytic Astro. | ||||||||
| Unknown | 1 (0.2%) | |||||||
| Tumor grade | ||||||||
| G1 | ||||||||
| G2 | 249 (48.3%) | 24 (20.5%) | ||||||
| G3 | 266 (51.6%) | 85 (73.7%) | 26 (100%) | 24 (100%) | ||||
| G4 | 153 (99.4%) | 159 (100%) | 59 (100%) | 76 (100%) | ||||
| Unknown | 1 (0.1%) | 1 (0.6%) | ||||||